All Stories

  1. Anticholinergic Burden in Individuals with Down Syndrome: An Examination of Risk and Clinical Implications
  2. The Gut Microbiota–Sex–Immunity Axis in Non-Communicable Diseases
  3. Inflammasomes in Cardiovascular Diseases: Current Knowledge and Future Perspectives
  4. Sex Differences in Cardiovascular Diseases: Exploring the Role of Microbiota and Immunity
  5. Advances in COVID-19 and Cancer Research
  6. Gut–Kidney–Heart: A Novel Trilogy
  7. The role of SARS-COV-2 infection in promoting abnormal immune response and sepsis: A comparison between SARS-COV-2-related sepsis and sepsis from other causes
  8. Effect of COVID-19 Vaccination on the In-Hospital Prognosis of Patients Admitted during Delta and Omicron Waves in Italy
  9. Current Evidence on Vaccinations in Pediatric and Adult Patients with Systemic Autoinflammatory Diseases
  10. Delirium in Head Trauma: Looking for a Culprit
  11. Risk Factors Associated with Post-Operative Complications in Multidisciplinary Treatment of Descending Necrotizing Mediastinitis
  12. The Role of Gut Microbiota in Heart Failure: When Friends Become Enemies
  13. Use of POCUS in Chest Pain and Dyspnea in Emergency Department: What Role Could It Have?
  14. Gut Microbiota and Chronic Diseases and Conditions
  15. The Crosstalk between Gut Microbiota, Intestinal Immunological Niche and Visceral Adipose Tissue as a New Model for the Pathogenesis of Metabolic and Inflammatory Diseases: The Paradigm of Type 2 Diabetes Mellitus
  16. Recent Advances in Vaccine Technology and Design
  17. Vaccines, Microbiota and Immunonutrition: Food for Thought
  18. Liver Injury in Patients Hospitalized for COVID-19: Possible Role of Therapy
  19. Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization
  20. Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: a pilot study
  21. Characteristics of patients with cancer in European long-term care facilities
  22. Microbiota and Myopericarditis: The New Frontier in the Car-Diological Field to Prevent or Treat Inflammatory Cardiomyo-Pathies in COVID-19 Outbreak
  23. Risk of burnout and stress in physicians working in a COVID team: A longitudinal survey
  24. Microbiota and Probiotics: The Role of Limosilactobacillus Reuteri in Diverticulitis
  25. Pollution, Inflammation, and Vaccines: A Complex Crosstalk
  26. Interaction between Lipopolysaccharide and Gut Microbiota in Inflammatory Bowel Diseases
  27. Gut Microbiota and Acute Diverticulitis: Role of Probiotics in Management of This Delicate Pathophysiological Balance
  28. Luteolin, inflammation and cancer: Special emphasis on gut microbiota
  29. Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World
  30. Angiotensin‐converting enzyme inhibitors or angiotensin II receptor blockers and prognosis of hypertensive patients hospitalised with COVID‐19
  31. The Interplay between Immunosenescence and Microbiota in the Efficacy of Vaccines
  32. COVID-19 and intestinal inflammation: Role of fecal calprotectin
  33. Physical performance measures and hospital outcomes among Italian older adults: results from the CRIME project
  34. Assessment of neurological manifestations in hospitalized patients with COVID‐19
  35. Letter: prevalence and patterns of gastrointestinal symptoms in a large Western cohort of patients with COVID‐19
  36. Interleukin-6 in Rheumatoid Arthritis
  37. Anticoagulant therapy in the treatment of splanchnic vein thrombosis associated to acute pancreatitis: a 3-year single-centre experience
  38. Risk factors for bloodstream infections in gynecological cancer
  39. Rationale for ozone-therapy as an adjuvant therapy in COVID-19: a narrative review
  40. Precision editing of the gut microbiota ameliorates cancer immunotherapy.
  41. Early oral vs parenteral nutrition in acute pancreatitis: a retrospective analysis of clinical outcomes and hospital costs from a tertiary care referral center
  42. Interrelationship between inflammatory cytokines (IL-1, IL-6, IL-33, IL-37) and acquired immunity.
  43. The Importance of Complying with Vaccination Protocols in Developed Countries: “Anti-Vax” Hysteria and the Spread of Severe Preventable Diseases
  44. The Interplay between Immunity and Microbiota at Intestinal Immunological Niche: The Case of Cancer
  45. An update in breast cancer management for elderly patients
  46. Integrins: Integrating the Biology and Therapy of Cell–cell Interactions
  47. Immune Modulation by Vitamin D: Special Emphasis on Its Role in Prevention and Treatment of Cancer